Skip to main content

Table 4 Characteristics of the studies included in the systematic review about Cmin (children)

From: Safety of linezolid in patients with decreased renal function and trough monitoring: a systematic review and meta-analysis

Study

Design of study

Country of study

Duration of therapy (days)

Age of children

No. of children

Cmin (μg/ml) of children

Thrombocytopenia

Non-thrombocytopenia

Cojutti 2015 [57]

Retrospective study

Italy

Group1 Median: 15.7

Group2 Median: 11

Group1 Mean:

4.9 ± 2.8

Group2 Mean: 14.9 ± 1.3

23 (8/15)

Median: 7.17

―

Kosaka 2009 [43]

Prospective study

Japan

Mean: 47.5 ± 48.4

Mean: 1.2 ± 0.8

4 (0/4)

―

0.1, 1.9, 2.7, 3.5, 4.1a

Matsumoto 2014 [44]

Prospective observational study

Japan

Mean: 17.8 ± 7.0

Mean: 6.4 ± 3.2

5 (1/4)

4.7b

1.4, 1.8, 4.4, 4.6

  1. aOne patient’ Cmin values were measured both after administered intravenously and orally
  2. bConcomitantly used methotrexate